Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...

Radella Pharmaceuticals reveals promising Phase 1b trial results for MD-18, showcasing significant weight loss and ...

GLP-1 medication users must consult physicians before surgery to mitigate anesthesia risks and ensure safe pre-operative ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...

Chai Discovery secures $70 million to revolutionize AI-driven drug discovery, enhancing antibody design and accelerating ...

Modeyso is the first and only approved treatment for recurrent H3 K27M-mutant diffuse midline glioma in patients aged one ...

Access inequity is driven by operational and bureaucratic challenges, affecting both low-income and developed nations, beyond ...

The talks are a result of the MFN order, which seeks to make US drug prices match lower prices in international markets.

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...

The supplemental New Drug Application is supported by data from the Phase II TRANSCEND FL trial (NCT04245839), which showed ...

Following the discontinuation of ALLO-647 due to a treatment-related death, Allogene will move forward with a streamlined ...

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with biological expertise to tackle complex diseases.